Global RWE & Health Outcomes Research Analyst
Location: Homebased / Hybrid
Sector: Pharmaceutical / Biotechnology
CY Partners is partnering with a leading global pharmaceutical organisation to recruit a Global Real-World Evidence (RWE) & Health Outcomes Research (HOR) Analyst / Epidemiologist. This role sits within a mature, globally integrated RWE & HOR function and supports a strategic, late-stage / marketed priority asset across its lifecycle.
This opportunity is well suited to candidates with hands-on experience working in, or closely with, the pharmaceutical industry, who are looking to deepen their impact in global evidence generation.
The Role
Reporting directly to the Global RWE & HOR Lead, you will contribute to the development and execution of asset-level real-world evidence strategies aligned to regulatory, access, and medical needs. You will work cross-functionally within a complex global matrix, collaborating closely with Medical Affairs, HEOR, Clinical Development, Market Access, and external research partners.
Key Responsibilities
-
Support asset-level RWE and HEOR strategy across development and/or lifecycle management
-
Contribute to the planning and delivery of Data Generation Plans (DGPs) aligned to regulatory, HTA, and payer evidence requirements
-
Design, execute, and oversee non-interventional studies (e.g. observational studies, registries, database studies)
-
Collaborate with internal stakeholders including Global Medical Affairs, HEOR, Market Access, Clinical, Biostatistics, and Regulatory
-
Manage and engage with external vendors, CROs, data owners, and academic collaborators
-
Support interpretation, scientific validation, and dissemination of RWE outputs (e.g. congresses, publications, internal decision-making)
-
Ensure studies meet internal governance, quality, and compliance standards typical of a global pharmaceutical organisation
Candidate Profile
-
MSc (or equivalent) in a relevant discipline, such as:
-
Demonstrable experience within the pharmaceutical or biotechnology industry, or in a consultancy/CRO supporting pharma clients
-
Practical experience delivering RWE and/or non-interventional studies in an industry setting
-
Familiarity with regulatory, HTA, or payer evidence expectations
-
Strong ability to operate within global, cross-functional matrix teams
-
Excellent stakeholder management and scientific communication skills
Why Apply?
This is an opportunity to work on a high-visibility global asset, contribute to evidence that directly informs regulatory, access, and medical strategy, and grow your career within a best-in-class pharmaceutical RWE & HEOR function.
For more information or a confidential discussion, please contact CY Partners.